---
title: "Merck & Co. Inc. Stock Underperforms Wednesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287115951.md"
description: "Merck & Co. Inc. (MRK) shares fell 1.09% to $113.00 on Wednesday, underperforming against competitors as the S&P 500 rose 1.08%. This decline ended a two-day winning streak, leaving the stock 9.70% below its 52-week high of $125.14. Trading volume was 9.0 million, slightly below the 50-day average of 9.3 million."
datetime: "2026-05-20T20:33:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287115951.md)
  - [en](https://longbridge.com/en/news/287115951.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287115951.md)
---

# Merck & Co. Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Merck & Co. Inc. (MRK) slipped 1.09% to $113.00 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.08% to 7,432.97 and the Dow Jones Industrial Average rising 1.31% to 50,009.35.

The stock's fall snapped a two-day winning streak.

Merck & Co. Inc. closed 9.70% short of its 52-week high of $125.14, which the company reached on February 25th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.30% to $229.32, Pfizer Inc. (PFE) rose 0.51% to $25.79, and Eli Lilly & Co. (LLY) fell 0.25% to $1,018.87.

Trading volume (9.0 M) remained 290,719 below its 50-day average volume of 9.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-20-26 1633ET

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Allworth Financial LP Grows Stake in Merck & Co., Inc. $MRK](https://longbridge.com/en/news/286522605.md)
- [Merck ADC, licensed from China, hits mark in first big global trial](https://longbridge.com/en/news/287075287.md)
- [Health Rounds: Widely used asthma drug may improve performance of cancer immunotherapies](https://longbridge.com/en/news/286957357.md)
- [ZAWYA: Merck marks World Hypertension Day with launch of Hypertension Risk Checker](https://longbridge.com/en/news/286918607.md)
- [Erasca Merck Pact Puts ERAS 0015 KEYTRUDA Combo In Investor Focus](https://longbridge.com/en/news/287222028.md)